Moderna, Inc.

MRNA

Quality scores

Data as of Sep 5, 2026

3 / 9

Weak

3/9 — WEAK fundamentals (a sign of low quality).

FailROA > 0 — ROA last year = -22.87 %
FailFCF > 0 — FCF last year = -2,065.00 mill.
PassFCF > net income (accrual quality) — FCF -2,065.00 vs. net income -2,822.00 (mill.)
PassRising ROA — ROA -22.87 % vs. prior year -25.18 %

FailLower long-term leverage — long-term debt/assets 0.05 vs. prior 0.00
FailRising current ratio (more liquidity) — Current ratio 3.29 vs. prior 3.67
FailNo dilution (shares do not grow) — Shares 394.00 mill. vs. prior 386.00 mill.

Z-Score (original)

10.62

Safe zone

Z''-Score (non-manufacturing)

8.37

Safe zone

Ratio	Value
X1 — Working capital / Total assets	0.37
X2 — Retained earnings / Total assets	0.59
X3 — EBIT / Total assets	-0.25
X4 — Market cap / Total liabilities	16.70
X4 — Book equity / Total liabilities	2.35
X5 — Sales / Total assets	0.16